We are live on
!
Find out more
RBF Capital Portfolio holdings
AUM
$2.41B
Turnover
12.01%
1-Year Est. Return
39.41%
This Fund
S&P 500
This Quarter
Est. Return
-16.46%
1 Year Est. Return
+39.41%
3 Year Est. Return
+146.98%
5 Year Est. Return
+207.22%
10 Year Est. Return
+1,174.87%
AUM
$1.44B
AUM Growth
-$126M
(-8.1%)
Cap. Flow
+$1.85M
Cap. Flow
% of AUM
0.13%
Top 10 Holdings %
Top 10 Hldgs %
26.11%
Holding
561
New
43
Increased
41
Reduced
67
Closed
36
Avg Time Held Equity + Options
3.7
years
Top 10 Avg Time Held Equity + Options
3.4
years
Top 20 Avg Time Held Equity + Options
4.7
years
Avg Time Held Equity only
3.7
years
Top 10 Avg Time Held Equity only
3.4
years
Top 20 Avg Time Held Equity only
4.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Uber
UBER
|
+$12.9M |
| 2 |
Willis Lease Finance
WLFC
|
+$2.77M |
| 3 |
Barclays
BCS
|
+$2.75M |
| 4 |
BGC Group
BGC
|
+$2.58M |
| 5 |
JD.com
JD
|
+$1.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$6.93M |
| 2 |
HBP
Huttig Building Products, Inc.
HBP
|
+$5.08M |
| 3 |
Amazon
AMZN
|
+$2.38M |
| 4 |
Purple Innovation
PRPL
|
+$2.33M |
| 5 |
OneSpaWorld
OSW
|
+$2.28M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 26.06% |
| 2 | Industrials | 13.73% |
| 3 | Consumer Discretionary | 11.76% |
| 4 | Technology | 11.67% |
| 5 | Miscellaneous | 7.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
FNHC
501
DELISTED
FedNat Holding Company Common Stock
FNHC
| $93K | 0.01% |
300,000
-173,843
| -37% | -$95K |
2013 Q2
36 quarters
|
|
502
Diversified Healthcare Trust
DHC
$1.85B
| $91K | 0.01% |
50,000
| – | – |
2021 Q2
4 quarters
|
|
503
DELISTED
Ampco-Pittsburgh Corp Series A Warrants
AP.WS
| $88K | 0.01% |
211,652
| – | – |
2020 Q4
6 quarters
|
|
|
IVC
504
DELISTED
Invacare Corporation
IVC
| $75K | 0.01% |
58,453
-41,547
| -42% | -$54.7K |
2021 Q4
2 quarters
|
|
|
SALM
505
DELISTED
Salem Media Group, Inc. Class A Common Stock
SALM
| $73K | 0.01% |
34,200
| – | – |
2020 Q2
8 quarters
|
|
|
AKUS
506
DELISTED
Akouos Inc
AKUS
| $72K | 0.01% |
+15,290
| New | +$54K |
2022 Q2
0 quarters
|
|
507
Quantum Corp
QMCO
$739M
| $68K | ﹤0.01% |
1,500
| – | – |
2021 Q4
2 quarters
|
|
508
Tuya Inc
TUYA
$1.02B
| $65K | ﹤0.01% |
24,800
| – | – |
2021 Q3
3 quarters
|
|
509
Marchex
MCHX
$56.3M
| $55K | ﹤0.01% |
41,600
| – | – |
2015 Q2
28 quarters
|
|
510
Shattuck Labs
STTK
$542M
| $53K | ﹤0.01% |
+13,000
| New | +$47.1K |
2022 Q2
0 quarters
|
|
511
Allot
ALLT
$441M
| $51K | ﹤0.01% |
10,360
| – | – |
2020 Q2
8 quarters
|
|
512
Taysha Gene Therapies
TSHA
$1.21B
| $51K | ﹤0.01% |
+13,800
| New | +$54.7K |
2022 Q2
0 quarters
|
|
513
DELISTED
CASI Pharmaceuticals
CASI
| $46K | ﹤0.01% |
15,936
-1
| -0% | -$4 |
2021 Q4
2 quarters
|
|
514
Regis Corp
RGS
$72.5M
| $44K | ﹤0.01% |
2,020
| – | – |
2021 Q4
2 quarters
|
|
|
CANG
515
Cango Inc
CANG
$127M
| $41K | ﹤0.01% |
1,826
| – | – |
2021 Q4
2 quarters
|
|
516
OnKure Therapeutics
OKUR
$85M
| $39K | ﹤0.01% |
+1,454
| New | +$33.8K |
2022 Q2
0 quarters
|
|
|
EVOL
517
DELISTED
Evolving Systems, Inc.
EVOL
| $37K | ﹤0.01% |
24,496
| – | – |
2020 Q2
8 quarters
|
|
518
Assembly Biosciences
ASMB
$414M
| $31K | ﹤0.01% |
1,228
| – | – |
2020 Q4
6 quarters
|
|
519
Xilio Therapeutics
XLO
$57.8M
| $29K | ﹤0.01% |
+719
| New | +$38K |
2022 Q2
0 quarters
|
|
520
Fortress Biotech
FBIO
$62M
| $25K | ﹤0.01% |
+2,000
| New | +$29.6K |
2022 Q2
0 quarters
|
|
|
WLMS
521
DELISTED
Williams Industrial Services Group Inc.
WLMS
| $19K | ﹤0.01% |
14,000
| – | – |
2021 Q1
5 quarters
|
|
522
DELISTED
ENGlobal Corp
ENG
| $18K | ﹤0.01% |
2,364
| – | – |
2013 Q2
36 quarters
|
|
523
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
| $15K | ﹤0.01% |
+583
| New | +$25.9K |
2022 Q2
0 quarters
|
|
524
CALL
AMC Entertainment Holdings
AMC
$2.53B
| – | – |
-2,900
| Closed | -$715K | – |
|
|
525
PUT
Amazon
AMZN
$2.69T
| – | – |
-20,000
| Closed | -$3.26M | – |
|
Similar funds
CI
LMC
RBF Capital's Q2 2022 Portfolio in Review
As of Q2 2022, RBF Capital held 561 positions worth $1.44B, down 8.1% from $1.56B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
RBF Capital's Q2 2022 filing shows 43 new, 41 increased, 67 reduced and 36 closed positions. Its largest new stake was BGC Group: 741,777 shares worth $2.5M. The largest sale was iPath Series B S&P 500 VIX Short-Term Futures ETN, an estimated $6.93M.
By sector, the portfolio is most concentrated in Financials at 26% of assets, up from 25% a quarter earlier, followed by Industrials and Consumer Discretionary.
- RBF Capital's largest Q2 2022 buy was BGC Group: 741,777 shares worth $2.5M.
- RBF Capital added most to Uber in Q2 2022, an estimated $12.9M increase.
- RBF Capital's biggest Q2 2022 reduction was iPath Series B S&P 500 VIX Short-Term Futures ETN, cutting an estimated $6.93M.
- RBF Capital fully exited Huttig Building Products, Inc. in Q2 2022, selling an estimated $5.08M.
- RBF Capital's ten largest holdings make up 26% of its $1.44B portfolio in Q2 2022.
- RBF Capital opened 43 new positions and closed 36 in Q2 2022.
- RBF Capital's portfolio value fell 8.1% quarter-over-quarter to $1.44B.
Based on RBF Capital's 13F filing for Q2 2022, filed 15 Aug 2022.